Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sight Sciences, Inc. Director's Dealing 2022

Feb 11, 2022

33763_dirs_2022-02-11_cd37807c-9b01-41f2-a72d-8db16f87dfb7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Sight Sciences, Inc. (SGHT)
CIK: 0001531177
Period of Report: 2022-02-09

Reporting Person: O'Neil Shawn (Chief Commercial Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-02-09 Restricted Stock Units $ A 18100 Acquired Common Stock (18100) Direct
2022-02-09 Stock Option (Right to Buy) $17.52 A 72300 Acquired 2032-02-09 Common Stock (72300) Direct

Footnotes

F1: Each Restricted Stock Unit represents a contingent right to receive one share of Issuer common stock.

F2: The Restricted Stock Units vest as to 25% on each of January 1, 2023; January 1, 2024; January 1, 2025 and January 1, 2026. The Restricted Stock Units have no expiration date.

F3: The options vest and become exercisable in 48 substantially equal monthly installments with the first installment vesting on February 1, 2022.